8 completed, 1 terminated. 9 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 9 | Completed 8, Terminated 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow FluMist: new trials by email Literature Review of FluMist trials Research Report on FluMist
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of FluMist With and Without Ampligen Poly I:Poly C12U 50 ug, Poly I:Poly C12U 200 ug, Poly I:Poly C12U 500 ug - Influenza, Human | Phase 1 / Phase 2 | Terminated | AIM ImmunoTech Inc. | 55 | 2012-04-01 | 2018-07-26 |
| A Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Adults 18 to 49 Years of Age Q/LAIV (MEDI3250), FluMist/B/Yamagata, FluMist/B/Victoria - Healthy or Stable Underlying Chronic Medical Condition | Phase 2 / Phase 3 | Completed | MedImmune LLC | 1800 | 2009-03-01 | 2011-12-05 |
| A Phase 2 Study to Evaluate Immune Responses of FluMist® TIV, Trivalent Inactivated Influenza Virus Vaccine, FluMist, Influenza Virus Vaccine Live - Influenza Vaccine | Phase 2 | Completed | MedImmune LLC | 101 | 2007-05-01 | 2021-10-06 |
| A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children Trivalent influenza virus vaccine live, intranasal - Healthy | Phase 2 | Completed | MedImmune LLC | 200 | 2006-05-01 | 2017-07-24 |
| Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV) CAIV-T, TIV - Influenza | Phase 2 | Completed | MedImmune LLC | 52 | 2005-05-01 | 2008-07-24 |
| Trial to Assess Safety, Efficacy, Tolerability and Immunogenicity of Influenza Virus Vaccine, Liquid Formulation (CAIV-T), Administered Concomitantly With a Combination Live, Attenuated, Mumps, Measles, and Rubella Vaccine in Healthy Children Aged 11 - 24 Months CAIV-T - Influenza | Phase 2 | Completed | MedImmune LLC | 1200 | 2002-10-01 | 2008-12-08 |
| Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine. CAIV-T, TIV, Placebo - Influenza | Phase 2 | Completed | MedImmune LLC | 31 | 2001-09-01 | 2012-02-14 |
| Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A and B, Live Cold-adapted (CAIV-T) in Healthy Children CAIV-T - Healthy | Phase 2 | Completed | MedImmune LLC | 498 | 2000-10-01 | 2012-03-06 |
| Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated influenza vaccine (IAIV) - HIV Infections, Influenza | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 300 | 2021-11-01 |
Influenza, Human (8) · HIV Infections (1)
MedImmune LLC (7) · AIM ImmunoTech Inc. (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (7) · Belgium (1) · Finland (1) · Puerto Rico (1) · Singapore (1)
Robert Walker, MD (2) · David R Strayer, MD (1) · Judith Falloon, M.D. (1) · Lucy Chai-See Lum, Prof. (1) · Maria Allende, M.D. (1) · Myron J. Levin, MD (1) · Raburn Mallory, M.D. (1) · Raburn Mallory, MD (1)